Chief Medical Officer
Dr. Greenhawt is an internationally recognized expert in allergy and immunology with deep expertise in food allergy, anaphylaxis, patient-centered care, and health services and health policy research. He brings extensive clinical, research, and advocacy experience to Aquestive. Dr. Greenhawt most recently served as Chief Medical Officer of the Asthma and Allergy Foundation of America (AAFA), the nation’s oldest and largest patient advocacy organization dedicated to people with asthma and allergic diseases. During his tenure, he advanced AAFA’s research initiatives and provided medical and scientific guidance for the organization’s educational, advocacy, and policy efforts. Prior to joining AAFA, Dr. Greenhawt served as Professor of Pediatrics at Children’s Hospital Colorado and the University of Colorado School of Medicine, where he directed the Food Challenge and Research Unit. He previously co-founded and co-directed the Pediatric Combined Eosinophilic Esophagitis Clinic and served as Research Director of the University of Michigan Food Allergy Center. Dr. Greenhawt is board certified in pediatrics and allergy/immunology and holds an MBA and MSc, in addition to his medical degree. He serves on multiple committees within the American Academy of Allergy, Asthma & Immunology (AAAAI) and the European Academy of Allergy and Clinical Immunology (EAACI). He is a past chair of the American College of Allergy, Asthma & Immunology (ACAAI) Food Allergy Committee and served a 10-year term on the AAAAI/ACAAI Joint Taskforce on Allergy Practice Parameters. He also served as an associate editor for the Annals of Allergy, Asthma, and Immunology from 2013 to 2021 and as the Journal’s senior associate editor from 2020 to 2026. Dr. Greenhawt was awarded the 2026 Distinguished Clinician Award from AAAAI. With more than 370 peer-reviewed publications, Dr. Greenhawt has made significant contributions to advancing the standard of care in allergy and immunology, with a particular focus on shared decision-making, patient preferences, and improving outcomes for people with food allergies.
